Cited 38 times in
Enlargement of the foveal avascular zone in diabetic retinopathy after adjunctive intravitreal bevacizumab (avastin) with pars plana vitrectomy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이성준 | - |
dc.contributor.author | 고형준 | - |
dc.date.accessioned | 2015-04-24T16:57:15Z | - |
dc.date.available | 2015-04-24T16:57:15Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 1080-7683 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/104483 | - |
dc.description.abstract | PURPOSE: The aim of this study was to describe a case of angiographically documented foveal avascular zone (FAZ) enlargement after intravitreal bevacizumab following vitrectomy and intravitreal bevacizumab treatment of a diabetic patient. METHODS: This study was done as a case report. RESULTS: A 40-year-old diabetic man was treated with a pars plana vitrectomy and intravitreal bevacizumab for a nonclearing vitreous hemorrhage. Despite successful surgery, the postoperative best-corrected visual acuity was not improved. FAZ area had increased from 1.48 mm(2) preoperatively to 1.96 mm(2) postoperatively (24.5% increase). CONCLUSIONS: Although intravitreal bevacizumab is an effective modality for diabetic retinopathy, it may deteriorate pre-existing retinal ischemia | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 173~174 | - |
dc.relation.isPartOf | JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Angiogenesis Inhibitors/adverse effects* | - |
dc.subject.MESH | Angiogenesis Inhibitors/therapeutic use | - |
dc.subject.MESH | Antibodies, Monoclonal/adverse effects* | - |
dc.subject.MESH | Antibodies, Monoclonal/therapeutic use | - |
dc.subject.MESH | Antibodies, Monoclonal, Humanized | - |
dc.subject.MESH | Bevacizumab | - |
dc.subject.MESH | Combined Modality Therapy | - |
dc.subject.MESH | Diabetic Retinopathy/drug therapy* | - |
dc.subject.MESH | Diabetic Retinopathy/surgery | - |
dc.subject.MESH | Fluorescein Angiography | - |
dc.subject.MESH | Fovea Centralis/blood supply | - |
dc.subject.MESH | Fovea Centralis/pathology* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Hypertrophy | - |
dc.subject.MESH | Injections | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Vitrectomy | - |
dc.subject.MESH | Vitreous Body | - |
dc.subject.MESH | Vitreous Hemorrhage/drug therapy* | - |
dc.subject.MESH | Vitreous Hemorrhage/surgery | - |
dc.title | Enlargement of the foveal avascular zone in diabetic retinopathy after adjunctive intravitreal bevacizumab (avastin) with pars plana vitrectomy | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Ophthalmology (안과학) | - |
dc.contributor.googleauthor | Sung Jun Lee | - |
dc.contributor.googleauthor | Hyoung Jun Koh | - |
dc.identifier.doi | 10.1089/jop.2008.0092 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02871 | - |
dc.contributor.localId | A00152 | - |
dc.relation.journalcode | J01654 | - |
dc.identifier.eissn | 1557-7732 | - |
dc.identifier.pmid | 19284326 | - |
dc.identifier.url | http://online.liebertpub.com/doi/abs/10.1089/jop.2008.0092 | - |
dc.contributor.alternativeName | Lee, Sung Jun | - |
dc.contributor.alternativeName | Koh, Hyoung Jun | - |
dc.contributor.affiliatedAuthor | Lee, Sung Jun | - |
dc.contributor.affiliatedAuthor | Koh, Hyoung Jun | - |
dc.citation.volume | 25 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 173 | - |
dc.citation.endPage | 174 | - |
dc.identifier.bibliographicCitation | JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, Vol.25(2) : 173-174, 2009 | - |
dc.identifier.rimsid | 54154 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.